pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    ML-061
    Docivyx (docetaxel)
    Adenocarcinoma Of The Gastroesophageal Junction Meridian Laboratories Inc
  • Preclinical
    MLN-33
    Melanoma$CNBX CNBX Pharmaceuticals Inc.
  • Phase 1
    MO-03
    Metastatic Renal Cell Carcinoma Osel Inc
  • Phase 1
← prev
page 27 of 62
next →
Pain89
Neurology1
MOMA-313
Metastatic Breast Cancer
Moma Therapeutics Inc
  • Preclinical
    MOMA-989
    Unspecified Cancer Moma Therapeutics Inc
  • Phase 2
    MP-0712
    Neuroendocrine Tumors$MOLN MOLECULAR PARTNERS AG
  • Phase 2
    MPB-1734
    Solid Tumor MegaPro Biomedical Co Ltd
  • Phase 2
    MRG-002
    Gastric Cancer Shanghai Miracogen Inc
  • Phase 2
    MRG-004A
    Solid Tumor Shanghai Miracogen Inc
  • Phase 2
    MRT-2359
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$GLUE Monte Rosa Therapeutics, Inc.
  • Phase 1
    MRX-2843
    Non-Small Cell Lung Cancer Meryx Inc
  • Phase 2
    MT-125
    Glioblastoma Multiforme (GBM) Myosin Therapeutics Inc
  • Phase 2
    MTG-201
    Prostate Cancer Momotaro-Gene Inc
  • Phase 1
    MTI-201
    Metastatic Uveal Melanoma Modulation Therapeutics Inc
  • Phase 2
    MTL-CEBPA
    Hepatocellular Carcinoma Mina Therapeutics Ltd
  • Preclinical
    MVP-0601
    Malignant Pleural Mesothelioma OncoVITA SAS
  • Phase 2
    MVRT-3011
    Recurrent Head And Neck Squamous Cell Carcinoma Immvira Co Ltd
  • Phase 2
    MWTx-01
    Polycythemia Vera$IRON Disc Medicine, Inc.
  • Preclinical
    MX-1604
    Liver Cancer Mesox Ltd
  • Phase 2
    MesoCancerVac
    MesoPher
    Malignant Mesothelioma Amphera BV
  • Marketed
    Metastron
    Metastron (strontium chloride sr 89)
    Bone Metastasis Q BioMed Inc
  • Preclinical
    MiNK-215
    Melanoma$INKT MiNK Therapeutics, Inc.
  • Phase 3
    Multikine
    Head And Neck Squamous Cell Carcinoma (HNSC) CEL-SCI Corp
  • Phase 2
    NB-003
    Gastrointestinal Stromal Tumor (GIST) NewBay Medical Technology Co Ltd
  • Phase 2
    NBM-BMX
    Metastatic Uveal Melanoma Novelwise Pharmaceutical Corp
  • Phase 2
    NC-410
    Cervical Cancer$NXTC NextCure, Inc.
  • Preclinical
    NED-170
    Bile Duct Cancer (Cholangiocarcinoma) NED Biosystems Inc
  • Phase 2
    NEO-100
    Recurrent Glioblastoma Multiforme (GBM)$NTHI NEONC TECHNOLOGIES HOLDINGS, INC.
  • Phase 2
    NEO-212
    Astrocytoma$NTHI NEONC TECHNOLOGIES HOLDINGS, INC.
  • Preclinical
    NERx-329
    Lung Cancer NERx BioSciences Inc